Interactions with Healthcare Professionals and patients

Lundbeck works with healthcare professionals when developing and delivering new treatment options to people living with psychiatric and neurological diseases. We believe this collaborative working benefits patients and society.

Research & Development (R&D)

Lundbeck undertakes research activities and conducts clinical studies globally. Clinical studies are conducted in accordance with international guidelines and performed by HCPs and HCOs. Our payments and other transfers of value related to pre-clinical, clinical and non-interventional studies are disclosed in aggregate.

 

  R&D payments to HCPs & HCOs  
Country 2015 2016 2017 2018
Austria €5,140 See country overview - -
Bulgaria €579,823 €319,234 €661,840 €1,349,624
Croatia 95,822 HRK 303,693 HRK €24,431 €295
Estonia - - €492,586 €235,171
Germany €2,812,493 See country overview  - -
Hungary €8,507 €30,128 €107,946 €52,271
Latvia See country overview €83,105 €199,889 €164,272
Lithuania €403,371 €229,952 €77,033 -
Serbia €251,289 Affiliate closed - -
Ukraine €896,803 €359,207 €99,857 €452,015

The amounts cover payments and other transfers of value to HCPs and HCOs related to pre-clinical, clinical and non-interventional studies in the countries where the Lundbeck affiliate uses Lundbeck’s corporate website for disclosure in accordance with the EFPIA Disclosure Code.

Data from other countries can be found on the Country overview tab.

Cookie Policy
You have chosen to leave www.lundbeck.com. Lundbeck does not have any responsibility for the content provided by other websites. Click "OK" to continue or "Cancel" to remain on www.lundbeck.com.